A C Lindgren1, L G Hellström, E M Ritzén, J Milerad. 1. Department of Woman and Child Health, Paediatric Endocrinology Unit, Karolinska Hospital, S-171 76 Stockholm, Sweden. Ann.Christin.Lindgren@kbh.ki.se
Abstract
UNLABELLED: We studied whether the beneficial effects of growth hormone (GH) treatment on growth and body composition in PWS are accompanied by an improvement in respiratory function. We measured resting ventilation, airway occlusion pressure (P(0.1)) and ventilatory response to CO(2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment. During GH treatment, resting ventilation increased by 26%, P(0.1) by 72% and the response to CO(2) by 65% (P < 0.002, <0.04 and <0.02, respectively). This observed increase in ventilatory output was not correlated to changes in body mass index. CONCLUSION: Treatment of children with Prader-Willi syndrome (PWS) seems to have a stimulatory effect on central respiratory structures. The observed increase in ventilation and inspiratory drive may contribute to the improved activity level reported by parents of PWS children during growth hormone therapy.
UNLABELLED: We studied whether the beneficial effects of growth hormone (GH) treatment on growth and body composition in PWS are accompanied by an improvement in respiratory function. We measured resting ventilation, airway occlusion pressure (P(0.1)) and ventilatory response to CO(2) in nine children, aged 7-14 years, before and 6-9 months after the start of GH treatment. During GH treatment, resting ventilation increased by 26%, P(0.1) by 72% and the response to CO(2) by 65% (P < 0.002, <0.04 and <0.02, respectively). This observed increase in ventilatory output was not correlated to changes in body mass index. CONCLUSION: Treatment of children with Prader-Willi syndrome (PWS) seems to have a stimulatory effect on central respiratory structures. The observed increase in ventilation and inspiratory drive may contribute to the improved activity level reported by parents of PWSchildren during growth hormone therapy.
Authors: Daan Caudri; Gillian M Nixon; Aleisha Nielsen; Linda Mai; Claire R Hafekost; Nitin Kapur; Chris Seton; Andrew Tai; Greg Blecher; Geoff Ambler; Philip B Bergman; Komal A Vora; Patricia Crock; Charles F Verge; Elaine Tham; Yassmin Musthaffa; Antony R Lafferty; Peter Jacoby; Andrew C Wilson; Jenny Downs; Catherine S Choong Journal: J Paediatr Child Health Date: 2021-08-16 Impact factor: 1.929
Authors: Jessica Duis; Lara C Pullen; Maria Picone; Norman Friedman; Stephen Hawkins; Elise Sannar; Anna C Pfalzer; Althea Robinson Shelton; Deepan Singh; Phyllis C Zee; Daniel G Glaze; Amee Revana Journal: J Clin Sleep Med Date: 2022-06-01 Impact factor: 4.324
Authors: Jennifer L Miller; Jonathan Shuster; Douglas Theriaque; Daniel J Driscoll; Mary Wagner Journal: J Clin Sleep Med Date: 2009-10-15 Impact factor: 4.062
Authors: A Salvatoni; E Veronelli; L Nosetti; J Berini; S de Simone; L Iughetti; L Bosio; G Chiumello; G Grugni; G Delù; P Castelnuovo; G Trifirò; L Nespoli Journal: J Endocrinol Invest Date: 2009-05-15 Impact factor: 4.256